MIM
NPTN

MetLife Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

MetLife Investment Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,961
Closed -$424K – 2878
2022
Q2 		$424K Hold
26,961
– – ﹤0.01% 1781
2022
Q1 		$410K Buy
26,961
+9,178
+52% +$140K ﹤0.01% 1896
2021
Q4 		$273K Buy
17,783
+8,371
+89% +$110K ﹤0.01% 1857
2021
Q3 		$82K Sell
9,412
-9,054
-49% -$82.5K ﹤0.01% 2501
2021
Q2 		$189K Buy
18,466
+7,865
+74% +$83K ﹤0.01% 2204
2021
Q1 		$127K Sell
10,601
-7,441
-41% -$84.4K ﹤0.01% 2227
2020
Q4 		$164K Hold
18,042
– – ﹤0.01% 2090
2020
Q3 		$110K Sell
18,042
-9,828
-35% -$75K ﹤0.01% 2174
2020
Q2 		$247K Buy
27,870
+9,797
+54% +$84.5K ﹤0.01% 1775
2020
Q1 		$131K Hold
18,073
– – ﹤0.01% 1933
2019
Q4 		$159K Hold
18,073
– – ﹤0.01% 2101
2019
Q3 		$110K Buy
18,073
+1,551
+9% +$8.72K ﹤0.01% 2281
2019
Q2 		$69.1K Hold
16,522
– – ﹤0.01% 2403
2019
Q1 		$104K Hold
16,522
– – ﹤0.01% 2304
2018
Q4 		$107K Hold
16,522
– – ﹤0.01% 2275
2018
Q3 		$137K Buy
+16,522
New +$126K ﹤0.01% 2292

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

MetLife Investment Management's NPTN Position: Q3 2022 in Review

MetLife Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 26,961 shares — an estimated $424K sold.

MetLife Investment Management first reported a position in NPTN in Q3 2018 and held it in 16 quarters. The position peaked at $424K in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • MetLife Investment Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • MetLife Investment Management sold 26,961 NEOPHOTONICS CORP shares in Q3 2022, an estimated $424K.
  • MetLife Investment Management first reported a position in NEOPHOTONICS CORP in Q3 2018 and held it in 16 quarters.
  • MetLife Investment Management's NEOPHOTONICS CORP position peaked at $424K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.